{
    "qwen-v2.5-14b-instruct": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to treat leukemia\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for leukemia"
            },
            "model": "qwen-v2.5-14b-instruct",
            "response": [
                "Imatinib (IM)",
                "Dasatinib",
                "Nilotinib",
                "Bosutinib",
                "Ponatinib",
                "Chlorambucil",
                "Cyclophosphamide",
                "Fludarabine",
                "Ibrutinib",
                "Venetoclax",
                "Obinutuzumab",
                "Ofatumumab",
                "Pentostatin",
                "Cladribine",
                "Alemtuzumab",
                "Bendamustine",
                "Lenalidomide",
                "Elotuzumab",
                "Daratumumab",
                "Midostaurin",
                "Blinatumomab",
                "Idecabtagene",
                "Tisagenlecleucel",
                "Pembrolizumab"
            ]
        }
    ],
    "phi-v4": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to treat leukemia\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for leukemia"
            },
            "model": "phi-v4",
            "response": [
                "Imatinib (Gleevec)",
                "Dasatinib (Sprycel)",
                "Nilotinib (Tasigna)",
                "Bosutinib (Bosulif)",
                "Ponatinib (Iclusig)",
                "Neratinib (Nerlynx)",
                "Taselisib (Jelpidio)",
                "Ibrutinib (Imbruvica)",
                "Venetoclax (Venclexta)",
                "Azacitidine (Vidaza)",
                "Decitabine (Dacogen)",
                "Cytarabine (Ara-C)",
                "Daunorubicin (Daunomycin)",
                "Idarubicin (Idamycin)",
                "Etoposide (VP-16, VePesid)",
                "Cyclophosphamide (Cytoxan, Neosar)",
                "Fludarabine (Fludara)",
                "Cladribine (Leustatin)",
                "Hydroxyurea (Hydrea)",
                "Busulfan (Myleran)",
                "Melphalan (Alkeran)",
                "Carmustine (BCNU, BiCNU)",
                "Temozolomide (Temodar)",
                "Etoposide phosphate (ETP)"
            ]
        }
    ],
    "mistral-small-instruct-24B": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to treat leukemia\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for leukemia"
            },
            "model": "mistral-small-instruct-24B",
            "response": [
                "Imatinib (Gleevec)",
                "Dasatinib (Sprycel)",
                "Nilotinib (Tasigna)",
                "Bosutinib (Bosulif)",
                "Ponatinib (Iclusig)",
                "Ruxolitinib (Jakafi)",
                "Vemurafenib (Zelboraf)",
                "Ibrutinib (Imbruvica)",
                "Idelalisib (Zydelig)",
                "Venetoclax (Venclexta)",
                "Omacetaxine (Synribo)",
                "Blinatumomab (Blincyto)",
                "Inotuzumab ozogamicin (Besponsa)",
                "Tisagenlecleucel (Kymriah)",
                "Axicabtagene ciloleucel (Yescarta)",
                "Midostaurin (Rydapt)",
                "Enasidenib (Idhifa)",
                "Ivosidenib (Tibsovo)",
                "Gilteritinib (Xospata)",
                "Tagraxofusp (Elzonris)",
                "Clofarabine (Clolar)",
                "Cytarabine (Ara-C)",
                "Daunorubicin (Cerubidine)",
                "Doxorubicin (Adriamycin)"
            ]
        }
    ],
    "gemma-3": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to treat leukemia\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for leukemia"
            },
            "model": "gemma-3",
            "response": [
                "Imatinib (GLEEVEC)",
                "Dasatinib (SPRYCEL)",
                "Nilotinib (TASIGNA)",
                "Bosutinib (BOSTIN)",
                "Ponatinib (IKSA)",
                "Venetoclax (VENCLYXTO)",
                "Cladribine (LEUSTAT)",
                "Fludarabine (FLUDARA)",
                "Cytarabine (CYTOSAR-U)",
                "Daunorubicin (DAUNOMYCIN)",
                "Doxorubicin (ADRIAMYCIN)",
                "Idarubicin (IDAMYCIN)",
                "Mitoxantrone (NOVANTRON)",
                "Gemtuzumab ozogamicin (MYLOTARG)",
                "Nelarabine (ARABINEX)",
                "Omacetaxine mepesuccinate (SYNRIBO)",
                "Vorinostat (ZOPOLE)",
                "Romidepsin (ISTODAX)",
                "Brentuximab vedotin (ADYCEVO)",
                "Inotuzumab ozogamicin (BESPONSA)",
                "Blinatumomab (BLINCYTO)",
                "Tisagenlecleucel (KYMRIAH)",
                "Axicabtagene ciloleucel (YESCARTA)",
                "Lisocabtagene maraleucel (BREYANZI)"
            ]
        }
    ],
    "gpt-4o": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to treat leukemia\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for leukemia"
            },
            "model": "gpt-4o",
            "response": [
                "Imatinib (Gleevec)",
                "Dasatinib (Sprycel)",
                "Nilotinib (Tasigna)",
                "Bosutinib (Bosulif)",
                "Ponatinib (Iclusig)",
                "Ibrutinib (Imbruvica)",
                "Venetoclax (Venclexta)",
                "Acalabrutinib (Calquence)",
                "Enasidenib (Idhifa)",
                "Midostaurin (Rydapt)",
                "Gilteritinib (Xospata)",
                "Omacetaxine mepesuccinate (Synribo)",
                "Ruxolitinib (Jakafi)",
                "Bendamustine (Treanda)",
                "Fludarabine (Fludara)",
                "Cladribine (Leustatin)",
                "Clofarabine (Clolar)",
                "Nelarabine (Arranon)",
                "Tisagenlecleucel (Kymriah)",
                "Blinatumomab (Blincyto)",
                "Inotuzumab ozogamicin (Besponsa)",
                "Obinutuzumab (Gazyva)",
                "Rituximab (Rituxan)",
                "Ofatumumab (Arzerra)"
            ]
        }
    ],
    "gpt-4o-mini": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to treat leukemia\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for leukemia"
            },
            "model": "gpt-4o-mini",
            "response": [
                "Imatinib (Gleevec)",
                "Dasatinib (Sprycel)",
                "Nilotinib (Tasigna)",
                "Bosutinib (Bosulif)",
                "Ponatinib (Iclusig)",
                "Venetoclax (Venclexta)",
                "Etoposide (VP-16)",
                "Cytarabine (Cytosar-U)",
                "Fludarabine (Fludara)",
                "Decitabine (Dacogen)",
                "Azacitidine (Vidaza)",
                "L-asparaginase (Elspar)",
                "Acalabrutinib (Calquence)",
                "Ruxolitinib (Jakafi)",
                "Midostaurin (Rydapt)",
                "Tisagenlecleucel (Kymriah)",
                "Clofarabine (Clolar)",
                "Inotuzumab ozogamicin (Besponsa)",
                "Mylotarg (Gemtuzumab ozogamicin)",
                "Nelarabine (Arranon)",
                "Blincyto (Blinatumomab)",
                "Carfilzomib (Kyprolis)",
                "Elotuzumab (Empliciti)",
                "Isunakinra (Acalabrutinib)",
                "Chimeric Antigen Receptor T-cell Therapy (CAR-T)"
            ]
        }
    ],
    "gpt-4-32k": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to treat leukemia\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for leukemia"
            },
            "model": "gpt-4-32k",
            "response": [
                "Gleevec (Imatinib)",
                "Sprycel (Dasatinib)",
                "Tasigna (Nilotinib)",
                "Bosulif (Bosutinib)",
                "Iclusig (Ponatinib)",
                "Rydapt (Midostaurin)",
                "Venclexta (Venetoclax)",
                "Rituxan (Rituximab)",
                "Arranon (Nelarabine)",
                "Clolar (Clofarabine)",
                "Campath (Alemtuzumab)",
                "Marqibo (Vincristine)",
                "Besponsa (Inotuzumab Ozogamicin)",
                "Mylotarg (Gemtuzumab Ozogamicin)",
                "Blincyto (Blinatumomab)",
                "Kymriah (Tisagenlecleucel)",
                "Yescarta (Axicabtagene Ciloleucel)",
                "Adcetris (Brentuximab Vedotin)",
                "Calquence (Acalabrutinib)",
                "Imbruvica (Ibrutinib)",
                "Venclexta (Venetoclax)",
                "Zydelig (Idelalisib)",
                "Verzenio (Abemaciclib)",
                "Tagrisso (Osimertinib)"
            ]
        }
    ],
    "gpt-35-turbo-16k": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to treat leukemia\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for leukemia"
            },
            "model": "gpt-35-turbo-16k",
            "response": [
                "Imatinib (Gleevec)",
                "Dasatinib (Sprycel)",
                "Nilotinib (Tasigna)",
                "Bosutinib (Bosulif)",
                "Ponatinib (Iclusig)",
                "Venetoclax (Venclexta)",
                "Midostaurin (Rydapt)",
                "Gilteritinib (Xospata)",
                "Enasidenib (Idhifa)",
                "Ivosidenib (Tibsovo)",
                "Gemtuzumab ozogamicin (Mylotarg)",
                "Tretinoin (Vesanoid)",
                "Arsenic trioxide (Trisenox)",
                "Clofarabine (Clolar)",
                "Cytarabine (Cytosar-U)",
                "Daunorubicin (Daunomycin)",
                "Idarubicin (Idamycin)",
                "Mitoxantrone (Novantrone)",
                "Cladribine (Leustatin)",
                "Fludarabine (Fludara)",
                "Mercaptopurine (Purinethol)",
                "Thioguanine (Tabloid)",
                "Hydroxyurea (Droxia)",
                "Busulfan (Busulfex)"
            ]
        }
    ],
    "o1-mini": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to treat leukemia\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for leukemia"
            },
            "model": "o1-mini",
            "response": [
                "Imatinib Mesylate (Gleevec)",
                "Dasatinib (Sprycel)",
                "Nilotinib (Tasigna)",
                "Bosutinib (Bosulif)",
                "Ponatinib (Iclusig)",
                "Ruxolitinib (Jakafi)",
                "Venetoclax (Venclexta)",
                "Fludarabine (Fludara)",
                "Cytarabine (Ara-C)",
                "Methotrexate",
                "Doxorubicin (Adriamycin)",
                "Vincristine (Oncovin)",
                "Prednisone",
                "Cyclophosphamide (Cytoxan)",
                "Clofarabine (Clolar)",
                "Alemtuzumab (Campath)",
                "Azacitidine (Vidaza)",
                "Decitabine (Dacogen)",
                "Midostaurin (Rydapt)",
                "Blinatumomab (Blincyto)",
                "Inotuzumab Ozogamicin (Besponsa)",
                "Brentuximab Vedotin (Adcetris)",
                "Gemtuzumab Ozogamicin (Mylotarg)",
                "Tretinoin (All-trans Retinoic Acid)"
            ]
        }
    ],
    "anthropic.claude-3-5-sonnet-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to treat leukemia\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for leukemia"
            },
            "model": "anthropic.claude-3-5-sonnet-v1:0",
            "response": [
                "Imatinib (Gleevec)",
                "Dasatinib (Sprycel)",
                "Nilotinib (Tasigna)",
                "Bosutinib (Bosulif)",
                "Ponatinib (Iclusig)",
                "Venetoclax (Venclexta)",
                "Rituximab (Rituxan)",
                "Obinutuzumab (Gazyva)",
                "Ofatumumab (Arzerra)",
                "Ibrutinib (Imbruvica)",
                "Acalabrutinib (Calquence)",
                "Idelalisib (Zydelig)",
                "Duvelisib (Copiktra)",
                "Gilteritinib (Xospata)",
                "Midostaurin (Rydapt)",
                "Quizartinib (Vanflyta)",
                "Gemtuzumab ozogamicin (Mylotarg)",
                "Blinatumomab (Blincyto)",
                "Inotuzumab ozogamicin (Besponsa)",
                "Arsenic trioxide (Trisenox)",
                "All-trans retinoic acid (ATRA)",
                "Cytarabine",
                "Daunorubicin",
                "Vincristine"
            ]
        }
    ],
    "anthropic.claude-3-opus-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to treat leukemia\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for leukemia"
            },
            "model": "anthropic.claude-3-opus-v1:0",
            "response": [
                "Imatinib (Gleevec)",
                "Dasatinib (Sprycel)",
                "Nilotinib (Tasigna)",
                "Bosutinib (Bosulif)",
                "Ponatinib (Iclusig)",
                "Asparaginase Erwinia chrysanthemi (Erwinaze)",
                "Rituximab (Rituxan)",
                "Obinutuzumab (Gazyva)",
                "Ofatumumab (Arzerra)",
                "Alemtuzumab (Campath)",
                "Blinatumomab (Blincyto)",
                "Inotuzumab ozogamicin (Besponsa)",
                "Tisagenlecleucel (Kymriah)",
                "Axicabtagene ciloleucel (Yescarta)",
                "Venetoclax (Venclexta)",
                "Enasidenib (Idhifa)",
                "Midostaurin (Rydapt)",
                "Gilteritinib (Xospata)",
                "Glasdegib (Daurismo)",
                "Tagraxofusp-erzs (Elzonris)",
                "Arsenic trioxide (Trisenox)",
                "Tretinoin (Vesanoid)",
                "Gemtuzumab ozogamicin (Mylotarg)",
                "Pegaspargase (Oncaspar)"
            ]
        }
    ],
    "anthropic.claude-3-sonnet-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to treat leukemia\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for leukemia"
            },
            "model": "anthropic.claude-3-sonnet-v1:0",
            "response": [
                "Imatinib (Gleevec)",
                "Dasatinib (Sprycel)",
                "Nilotinib (Tasigna)",
                "Ponatinib (Iclusig)",
                "Bosutinib (Bosulif)",
                "Asciminib (Scemblix)",
                "Venetoclax (Venclexta)",
                "Glasdegib (Daurismo)",
                "Gilteritinib (Xospata)",
                "Enasidenib (Idhifa)",
                "Gemtuzumab ozogamicin (Mylotarg)",
                "Inotuzumab ozogamicin (Besponsa)",
                "Blinatumomab (Blincyto)",
                "Liposomal cytarabine (DepoCyt)",
                "Cladribine (Leustatin)",
                "Clofarabine (Clolar)",
                "Nelarabine (Arranon)",
                "Vincristine liposomal (Marqibo)",
                "Omacetaxine mepesuccinate (Synribo)",
                "Decitabine (Dacogen)",
                "Azacitidine (Vidaza)",
                "Midostaurin (Rydapt)"
            ]
        }
    ],
    "anthropic.claude-3-haiku-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to treat leukemia\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for leukemia"
            },
            "model": "anthropic.claude-3-haiku-v1:0",
            "response": [
                "Imatinib (Gleevec)",
                "Dasatinib (Sprycel)",
                "Nilotinib (Tasigna)",
                "Bosutinib (Bosulif)",
                "Ponatinib (Iclusig)",
                "Venetoclax (Venclexta)",
                "Blinatumomab (Blincyto)",
                "Clofarabine (Clolar)",
                "Nelarabine (Arranon)",
                "Asparaginase (Elspar)",
                "Cladribine (Leustatin)",
                "Fludarabine (Fludara)",
                "Pentostatin (Nipent)",
                "Clofarabine (Clolar)",
                "Cytarabine (Cytosar-U)",
                "Daunorubicin (Cerubidine)",
                "Idarubicin (Idamycin)",
                "Mitoxantrone (Novantrone)",
                "Etoposide (Toposar)",
                "Teniposide (Vumon)",
                "Tretinoin (Vesanoid)",
                "Arsenic trioxide (Trisenox)",
                "Gemtuzumab ozogamicin (Mylotarg)",
                "Bortezomib (Velcade)"
            ]
        }
    ],
    "meta.llama3-8b-instruct-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to treat leukemia\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for leukemia"
            },
            "model": "meta.llama3-8b-instruct-v1:0",
            "response": [
                "Hydroxyurea (Hydrea)",
                "Busulfan",
                "Cytarabine",
                "Daunorubicin",
                "Mitoxantrone",
                "Vincristine",
                "Mercaptopurine",
                "Purinethol",
                "Cladribine",
                "Fludarabine",
                "Idarubicin",
                "Asparaginase",
                "Clofarabine",
                "Nelarabine",
                "Pegaspargase",
                "Clofarabine",
                "Mitoxantrone",
                "Gemtuzumab ozogamicin",
                "Blincyto",
                "Blinatumomab",
                "Inotuzumab ozogamicin",
                "Ibrutinib",
                "Blinatumomab",
                "Ixazomib",
                "Bosutinib",
                "Ibrutinib"
            ]
        }
    ],
    "meta.llama3-70b-instruct-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to treat leukemia\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for leukemia"
            },
            "model": "meta.llama3-70b-instruct-v1:0",
            "response": [
                "Midostaurin (PKC412)",
                "Gilteritinib (ASP2215)",
                "Enasidenib (AG-221)",
                "Ivosidenib (AG-120)",
                "Tretinoin (Vesanoid)",
                "Arsenic trioxide (Trisenox)",
                "Tisagenlecleucel (Kymriah)",
                "Axicabtagene ciloleucel (Yescarta)",
                "Ponatinib (Iclusig)",
                "Bosutinib (Bosulif)",
                "Dasatinib (Sprycel)",
                "Nilotinib (Tasigna)",
                "Imatinib (Gleevec)",
                "Omacetaxine mepesuccinate (Synribo)",
                "Clofarabine (Colzar)",
                "Decitabine (Dacogen)",
                "Fludarabine phosphate (Fludara)",
                "Cladribine (Leustatin)",
                "Nelarabine (Arranon)",
                "Cyclophosphamide (Cytoxan)",
                "Ifosfamide (Ifex)",
                "Melphalan (Alkeran)",
                "Bendamustine (Treanda)",
                "Chlorambucil (Leukeran)"
            ]
        }
    ],
    "amazon.titan-text-express-v1": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to treat leukemia\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for leukemia"
            },
            "model": "amazon.titan-text-express-v1",
            "response": [
                {
                    "Referent": "Imatinib mesylate (Gleevec)",
                    "Canonical name": "Imatinib mesylate"
                },
                {
                    "Referent": "Dasatinib (Sprycel)",
                    "Canonical name": "Dasatinib"
                },
                {
                    "Referent": "Nilotinib (Tasigna)",
                    "Canonical name": "Nilotinib"
                },
                {
                    "Referent": "Bosutinib (Bosulif)",
                    "Canonical name": "Bosutinib"
                },
                {
                    "Referent": "Ponatinib (Iclusig)",
                    "Canonical name": "Ponatinib"
                }
            ]
        }
    ]
}